Annual EBIT
-$30.46 M
-$12.41 M-68.75%
December 31, 2023
Summary
- As of March 7, 2025, UNCY annual earnings before interest & taxes is -$30.46 million, with the most recent change of -$12.41 million (-68.75%) on December 31, 2023.
- During the last 3 years, UNCY annual EBIT has fallen by -$28.44 million (-1408.02%).
- UNCY annual EBIT is now -1408.02% below its all-time high of -$2.02 million, reached on December 31, 2020.
Performance
UNCY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$4.08 M
-$13.95 M-141.34%
September 30, 2024
Summary
- As of March 7, 2025, UNCY quarterly earnings before interest & taxes is -$4.08 million, with the most recent change of -$13.95 million (-141.34%) on September 30, 2024.
- Over the past year, UNCY quarterly EBIT has increased by +$3.70 million (+47.54%).
- UNCY quarterly EBIT is now -141.34% below its all-time high of $9.87 million, reached on June 30, 2024.
Performance
UNCY Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$22.93 M
+$234.00 K+1.01%
September 30, 2024
Summary
- As of March 7, 2025, UNCY TTM earnings before interest & taxes is -$22.93 million, with the most recent change of +$234.00 thousand (+1.01%) on September 30, 2024.
- Over the past year, UNCY TTM EBIT has increased by +$7.53 million (+24.72%).
- UNCY TTM EBIT is now -6605.26% below its all-time high of -$342.00 thousand, reached on March 31, 2020.
Performance
UNCY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
UNCY EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -68.8% | +47.5% | +24.7% |
| 3 y3 years | -1408.0% | +47.5% | +24.7% |
| 5 y5 years | -1403.5% | +47.5% | +24.7% |
UNCY EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -224.4% | at low | -141.3% | +80.5% | -144.2% | +37.8% |
| 5 y | 5-year | -1408.0% | at low | -141.3% | +80.5% | -6605.3% | +37.8% |
| alltime | all time | -1408.0% | at low | -141.3% | +80.5% | -6605.3% | +37.8% |
Unicycive Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.08 M(-141.3%) | -$22.93 M(-1.0%) |
| Jun 2024 | - | $9.87 M(-147.1%) | -$23.17 M(-37.1%) |
| Mar 2024 | - | -$20.94 M(+169.2%) | -$36.84 M(+20.9%) |
| Dec 2023 | -$30.46 M(+68.7%) | -$7.78 M(+80.3%) | -$30.46 M(+8.8%) |
| Sep 2023 | - | -$4.32 M(+13.4%) | -$28.01 M(-4.2%) |
| Jun 2023 | - | -$3.81 M(-73.9%) | -$29.25 M(+0.6%) |
| Mar 2023 | - | -$14.56 M(+173.5%) | -$29.08 M(+61.1%) |
| Dec 2022 | -$18.05 M | -$5.33 M(-4.1%) | -$18.05 M(+16.6%) |
| Sep 2022 | - | -$5.55 M(+52.8%) | -$15.48 M(+2.7%) |
| Jun 2022 | - | -$3.64 M(+2.8%) | -$15.07 M(+23.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$3.54 M(+28.5%) | -$12.21 M(+30.1%) |
| Dec 2021 | -$9.39 M(+364.8%) | -$2.75 M(-46.5%) | -$9.39 M(+27.7%) |
| Sep 2021 | - | -$5.15 M(+560.6%) | -$7.35 M(+159.5%) |
| Jun 2021 | - | -$779.00 K(+9.4%) | -$2.83 M(+18.5%) |
| Mar 2021 | - | -$712.00 K(-0.7%) | -$2.39 M(+18.3%) |
| Dec 2020 | -$2.02 M(-0.3%) | - | - |
| Dec 2020 | - | -$717.00 K(+14.5%) | -$2.02 M(+55.0%) |
| Sep 2020 | - | -$626.00 K(+86.3%) | -$1.30 M(+92.3%) |
| Jun 2020 | - | -$336.00 K(-1.8%) | -$678.00 K(+98.2%) |
| Mar 2020 | - | -$342.00 K | -$342.00 K |
| Dec 2019 | -$2.03 M | - | - |
FAQ
- What is Unicycive Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Unicycive Therapeutics?
- What is Unicycive Therapeutics annual EBIT year-on-year change?
- What is Unicycive Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Unicycive Therapeutics?
- What is Unicycive Therapeutics quarterly EBIT year-on-year change?
- What is Unicycive Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Unicycive Therapeutics?
- What is Unicycive Therapeutics TTM EBIT year-on-year change?
What is Unicycive Therapeutics annual earnings before interest & taxes?
The current annual EBIT of UNCY is -$30.46 M
What is the all time high annual EBIT for Unicycive Therapeutics?
Unicycive Therapeutics all-time high annual earnings before interest & taxes is -$2.02 M
What is Unicycive Therapeutics annual EBIT year-on-year change?
Over the past year, UNCY annual earnings before interest & taxes has changed by -$12.41 M (-68.75%)
What is Unicycive Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of UNCY is -$4.08 M
What is the all time high quarterly EBIT for Unicycive Therapeutics?
Unicycive Therapeutics all-time high quarterly earnings before interest & taxes is $9.87 M
What is Unicycive Therapeutics quarterly EBIT year-on-year change?
Over the past year, UNCY quarterly earnings before interest & taxes has changed by +$3.70 M (+47.54%)
What is Unicycive Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of UNCY is -$22.93 M
What is the all time high TTM EBIT for Unicycive Therapeutics?
Unicycive Therapeutics all-time high TTM earnings before interest & taxes is -$342.00 K
What is Unicycive Therapeutics TTM EBIT year-on-year change?
Over the past year, UNCY TTM earnings before interest & taxes has changed by +$7.53 M (+24.72%)